Aurobindo Pharma incurring loss at China Plant; hopes to achieve break-even by Q4 0 23.11.2025 10:09 Thehindubusinessline.com In the US, Dayton (facility) has transitioned into the commercial phase, with manufacturing underway, packaging approval secured, and product launches scheduled from January, positioning the site to start contributing significant revenues in FY27 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
